Source: WHO guidelines This reinforces the need for employers and insurers to ensure that GLP-1 utilization aligns with recognised medical criteria not social demand, cosmetic goals, or convenience-based prescribing
Further assessment of data for the 72-week study of adults without diabetes, showed the percent who saw 25% body weight loss (57-58 lbs) were 15.3% for 5 mg, 32.3% for 10 mg, 36.2% for 15 mg and 1.5% for placebo
Your provider may record weight and body measurements and decide whether you need laboratory testing or additional medical clearance
Magnesium glycinate is typically considered to be safe to use alongside GLP-1 medications such as semaglutide or tirzepatide. Our expert says GLP-1 users have been consistently identified as at risk of micronutrient deficiencies, including magnesium deficiency, so it is paramount to discuss this possibility with the physician who prescribed the meds
Even compounded versions, while cheaper, represent a significant investment